These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 26946951

  • 1. Is the use of esomeprazole in gastroesophageal reflux disease a cost-effective option in Poland?
    Petryszyn P, Staniak A, Grzegrzolka J.
    J Comp Eff Res; 2016 Mar; 5(2):169-78. PubMed ID: 26946951
    [Abstract] [Full Text] [Related]

  • 2. The efficacy, safety and cost-effectiveness of hydrotalcite versus esomeprazole in on-demand therapy of NERD: A multicenter, randomized, open-label study in China.
    Xiao YL, Nie YQ, Hou XH, Xie PY, Fang JY, Yuan YZ, Zhou LY, Zhao NQ, Chen MH.
    J Dig Dis; 2013 Sep; 14(9):463-8. PubMed ID: 23659834
    [Abstract] [Full Text] [Related]

  • 3. A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis.
    Raghunath AS, Green JR, Edwards SJ.
    Clin Ther; 2003 Jul; 25(7):2088-101. PubMed ID: 12946553
    [Abstract] [Full Text] [Related]

  • 4. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
    Jonasson C, Tvete IF, Hatlebakk JG.
    Scand J Gastroenterol; 2013 Sep; 48(9):1010-7. PubMed ID: 23859491
    [Abstract] [Full Text] [Related]

  • 5. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V, Youssef NN, Gilger MA, Traxler B, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26121347
    [Abstract] [Full Text] [Related]

  • 6. Cost analysis of long-term treatment of patients with symptomatic gastroesophageal reflux disease (GERD) with esomeprazole on-demand treatment or esomeprazole continuous treatment: an open, randomized, multicenter study in Switzerland.
    Szucs T, Thalmann C, Michetti P, Beglinger C.
    Value Health; 2009 Jul; 12(2):273-81. PubMed ID: 18783388
    [Abstract] [Full Text] [Related]

  • 7. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V, Youssef NN, Gilger MA, Traxler B, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26422095
    [Abstract] [Full Text] [Related]

  • 8. Cost-utility analysis of a 'vonoprazan-first' strategy versus 'esomeprazole- or rabeprazole-first' strategy in GERD.
    Yokoya Y, Igarashi A, Uda A, Deguchi H, Takeuchi T, Higuchi K.
    J Gastroenterol; 2019 Dec; 54(12):1083-1095. PubMed ID: 31396703
    [Abstract] [Full Text] [Related]

  • 9. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V, Gilger MA, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26121348
    [Abstract] [Full Text] [Related]

  • 10. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V, Gilger MA, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [Abstract] [Full Text] [Related]

  • 11. Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.
    Tonini M, Vigneri S, Neri M, Cuomo R, Savarino V, Pace F.
    Digestion; 2007 Jul; 76(3-4):171-8. PubMed ID: 18046084
    [Abstract] [Full Text] [Related]

  • 12. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P, van Zanten SV, Mattsson H, Wernersson B.
    Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.
    Teng M, Khoo AL, Zhao YJ, Lin L, Lim BP, Wu TS, Dan YY.
    J Clin Pharm Ther; 2015 Aug; 40(4):368-75. PubMed ID: 25893507
    [Abstract] [Full Text] [Related]

  • 14. The concept of complete remission of gastro-oesophageal reflux disease : comparative efficacy of pantoprazole and esomeprazole using the ReQuest questionnaire.
    Thomson AB.
    Clin Drug Investig; 2007 Aug; 27(10):663-72. PubMed ID: 17803341
    [Abstract] [Full Text] [Related]

  • 15. Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study).
    Lu B, Zhang L, Wang J, Wang B, Zou X, Fei G, Chen D, Wang X, Wu B, Zou D.
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1722-1727. PubMed ID: 29575167
    [Abstract] [Full Text] [Related]

  • 16. Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease.
    Wu MS, Tan SC, Xiong T.
    Aliment Pharmacol Ther; 2013 Jul; 38(2):190-201. PubMed ID: 23718547
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the effectiveness of esomeprazole treatment strategies in the management of patients with gastroesophageal reflux disease symptoms: a meta-analysis.
    Mei J, Yu Y, Ma J, Yu X.
    Pharmazie; 2016 May; 71(5):285-91. PubMed ID: 27348974
    [Abstract] [Full Text] [Related]

  • 18. Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial.
    Tan VP, Wong WM, Cheung TK, Lai KC, Hung IF, Chan P, Pang R, Wong BC.
    J Gastroenterol; 2011 Jul; 46(7):906-12. PubMed ID: 21538030
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study.
    Goh KL, Benamouzig R, Sander P, Schwan T, EMANCIPATE.
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):205-11. PubMed ID: 17301646
    [Abstract] [Full Text] [Related]

  • 20. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.
    Labenz J, Armstrong D, Lauritsen K, Katelaris P, Schmidt S, Schütze K, Wallner G, Juergens H, Preiksaitis H, Keeling N, Nauclér E, Adler J, Eklund S.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):803-11. PubMed ID: 16225489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.